Author Correction: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma

MLA

Sarah E. Woodfield, et al. “Author Correction: MDM4 Inhibition: A Novel Therapeutic Strategy to Reactivate P53 in Hepatoblastoma.” Scientific Reports, vol. 11, no. 1, Oct. 2021, p. 1. EBSCOhost, https://doi.org/10.1038/s41598-021-98174-7.

APA

Sarah E. Woodfield, Yan Shi, Roma H. Patel, Zhenghu Chen, Aayushi P. Shah, Rohit K. Srivastava, Richard S. Whitlock, Aryana M. Ibarra, Samuel R. Larson, Stephen F. Sarabia, Andrew Badachhape, Zbigniew Starosolski, Ketan B. Ghaghada, Pavel Sumazin, D. Allen Annis, Dolores López-Terrada, & Sanjeev A. Vasudevan. (2021). Author Correction: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Scientific Reports, 11(1), 1. https://doi.org/10.1038/s41598-021-98174-7

Chicago

Sarah E. Woodfield, Yan Shi, Roma H. Patel, Zhenghu Chen, Aayushi P. Shah, Rohit K. Srivastava, Richard S. Whitlock, et al. 2021. “Author Correction: MDM4 Inhibition: A Novel Therapeutic Strategy to Reactivate P53 in Hepatoblastoma.” Scientific Reports 11 (1): 1. doi:10.1038/s41598-021-98174-7.